We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




New Surgical Technique Helps Treat Pseudogynecomastia

By HospiMedica International staff writers
Posted on 02 Jul 2020
Print article
Image: Illustration of preoperative markings and pertinent reference points (Courtesy of UT Soutwestern)
Image: Illustration of preoperative markings and pertinent reference points (Courtesy of UT Soutwestern)
A novel excisional approach helps male patients with pseudogynecomastia following massive weight loss (MWL), according to a new study.

Developed by researchers at the University of Texas (UT) Southwestern Medical Centre (Dallas, TX, USA) and in private practice, the technique involves a modified elliptical excision and nipple-areola complex (NAC) transposition on a thinned inferior dermal pedicle, in addition to liposuction, as an alternative to conventional mastopexy body contouring procedures for treating male chest deformity after MWL, which often leads to suboptimal results. The researchers reported the results of a retrospective chart review in 14 male patients, who were followed for an average of 8.1 months.

The patients were characterized by age, method of weight loss, pre-weight loss body mass index (BMI), post-weight loss BMI, total weight loss, grade of pseudogynecomastia, and concurrent procedures. The average weight lost was 79.72 kg, with pre-weight loss BMI averaging 52.0 kg/m2 and post-weight loss BMI 29.6 kg/m2. The average amount of tissue removed was 2,615 grams. In all, 28.6% of the patients experienced minor complications, including asymmetry, delayed wound healing, hyperpigmentation, and seroma. There were no wound infections, hematomas, flap necrosis, or dysesthesia. The study was published on June 16, 2020, in Aesthetic Surgery Journal: Open Forum.

“Due to several cosmetic advantages and low complication profile, our technique is an attractive option for treating male chest deformity after MWL,” concluded senior author Professor Jeffrey Kenkel, MD, of UT Southwestern Medical Center, and colleagues. “This is a nice alternative to the standard nipple grafting techniques we have used for years. It allows us to preserve the shape of the nipple and in many cases the color in patients of color.”

Pseudogynecomastia is defined by retained retroareolar fat without glandular hypertrophy, often with excess tissue and skin anteriorly and laterally; this in contrast to gynecomastia, which is often idiopathic and results in proliferation of glandular tissue. Treatment for pseudogynecomastia generally requires excision of excess tissue and skin for all but the mildest forms.

Related Links:
University of Texas Southwestern Medical Centre

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Multilevel Self-Loading Stretcher
CARRERA XL

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.